RYDAPT

Identification of Rydapt

No description

Google image searchProduct monograph

Active ingredient

midostaurin, 25 MG

DIN: 02466236

Dosage form(s): CAPSULE

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 08-SEP-2017

ATC:

• L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
• L01E — PROTEIN KINASE INHIBITORS (ATC, ATC/DDD)
• L01EX — Other protein kinase inhibitors (ATC, ATC/DDD)
• L01EX10 — MIDOSTAURIN (ATC/DDD)

External Links for Rydapt

Search on Google

• Rydapt side effects
• Rydapt dosage
• midostaurin side effects
• midostaurin dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find rydapt photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.